ISO 13485 Certification in the US

Organizations generally begin by defining the medical device quality management system scope, understanding ISO 13485:2016 requirements, documenting and implementing applicable processes, and evaluating readiness through internal audit and management review. Certification itself is performed by an external certification body, not by a training provider. QMS Learning supports preparation through training covering design controls, document control, CAPA, risk management, management review, and internal audit.

ISO 13485 certification is not universally mandatory for every medical device organization, but requirements can depend on the markets served, device classification, regulatory pathway, contracts, and customer expectations. In the United States, FDA quality system requirements are especially important, while ISO 13485 may provide an internationally recognized framework. Teams should evaluate applicable regulatory and commercial obligations before deciding whether certification is appropriate.

ISO 13485:2016 establishes requirements for a quality management system used by organizations involved in the medical device lifecycle. Relevant topics include organizational processes, documentation, management responsibility, resource management, product realization, design controls, purchasing, production, measurement, analysis, improvement, CAPA, and internal audit. The standard is intended to support consistent processes and the ability to meet customer and regulatory requirements.

ISO 13485:2016 is an international medical device quality management standard, while FDA 21 CFR Part 820 is the United States Quality System Regulation. They address related quality system topics but are not identical requirements. QMS Learning treats them as distinct areas within its Medical Device & Life Sciences QMS Training Pathway, alongside inspection readiness, Form 483 response, and the FDA Quality System Inspection Technique approach.

A medical device QMS should address the processes and records applicable to the organization’s products and activities. Common areas include controlled documents, design controls, risk management, supplier and purchasing controls, production records, training, complaints, nonconformities, CAPA, internal audit, and management review. The specific documentation structure should reflect the organization’s scope, products, regulatory obligations, and operational responsibilities.

ISO 14971 addresses risk management for medical devices, including hazard identification, risk evaluation, risk control, residual risk acceptability, and continued risk management through post-market surveillance. ISO 13485 provides the broader quality management system framework in which risk-based processes operate. QMS Learning offers separate ISO 14971 Risk Management training and includes it in the Medical Device & Life Sciences QMS Training Pathway.

No. Training helps personnel understand requirements and develop the capability to implement and maintain a quality management system, but it does not itself grant ISO 13485 certification. Certification involves an assessment by an external certification body against the applicable standard and the organization’s implemented system. Training can support readiness by strengthening knowledge, documented processes, internal audit preparation, and evidence management.

QMS Learning’s ISO 13485 training is designed for medical device QMS managers and regulatory affairs professionals. The broader pathway is intended for medical device manufacturers and life sciences companies working with ISO 13485 and FDA 21 CFR Part 820 requirements. The course includes role-profile onboarding, AI Workbench access, Manager Dashboard visibility, and Audit-Evidence Package export to support team-based capability building.